Objectives: Hemolysis is a known complication of pediatric extracorporeal membrane oxygenation associated with renal failure and mortality. We sought to identify predictors of hemolysis in pediatric extracorporeal membrane oxygenation patients and determine its influence on outcomes. Design: Retrospective, single-center study. Setting: Urban, quaternary care center pediatric and neonatal ICU. Patients: Ninety-six patients requiring extracorporeal membrane oxygenation. Interventions: None. Measurements and Main Results: Daily measurements of plasma-free hemoglobin were obtained while patients were on extracorporeal membrane oxygenation. Patients with a prior extracorporeal membrane oxygenation run, on extracorporeal membrane oxygenation for less than 24 hours, or without complete medical records were excluded from the study. Ninety-six patients met inclusion criteria, of which, 25 patients (26%) had plasma-free hemoglobin greater than 30 mg/dL. Of those patients, 15 of 25(60%) had plasma-free hemoglobin greater than 50 mg/dL, and 21 of 25(84%) occurred during the first 7 days on extracorporeal membrane oxygenation. Compared with patients without hemolysis, those with hemolysis were younger (0.2 mo [0.06–3.2 mo] vs 8.2 mo [0.6–86 mo]; p 30 mg/dL) had a 10-fold increase in in-hospital mortality. In our study cohort, hemolysis was associated with continuous ultrafiltration use, but not continuous renal replacement therapy. Additionally, our results suggest that the degree of coagulopathy (international normalized ratio > 3.5) at the time of cannulation influences hemolysis. Additional prospective studies are necessary to define further strategies to prevent hemolysis and improve outcomes in pediatric extracorporeal membrane oxygenation patients. This work was performed at Columbia University Herbert and Florence Irving Medical Center, Morgan-Stanley Children’s Hospital of New York-Presbyterian. The authors have disclosed that they do not have any potential conflicts of interest. For information regarding this article, E-mail: so2462@cumc.columbia.edu ©2018The Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies
from Emergency Medicine via xlomafota13 on Inoreader https://ift.tt/2OwKLx8
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
EDITORIAL Pediatric retina: A challenging yet fascinating field p. 179 Wei-Chi Wu DOI :10.4103/tjo.tjo_123_18 [HTML Full text] [PDF] ...
-
Medicine by Alexandros G. Sfakianakis MDPI CancersCancers, Vol. 12, Pages 279: Metabolism of Estrogens: Turnover Differs Between Platinum-...
-
Abstract The aim of many breeding programs for the conservation of genetic biodiversity is to preserve the genetic resources of wild speci...
-
Medicine by Alexandros G. Sfakianakis,Αλέξανδρος Γ. Σφακιανάκης Anaphylaxis Refractory to intra‐muscular adrenaline Anaphylaxis Refractory ...
-
Medicine by Alexandros G. Sfakianakis , Cancer ScienceMdm2 – open questionsAbstract The Mdm2 oncoprotein and its association with p53 were...
-
Helicobacter pylori infection and gastrointestinal tract cancer biology: considering a double-edged sword reflection Adult stem cells at wor...
-
# Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182, High level MYC amplification in B-ce...
-
Journal of visualized experiments : JoVE,http://www.jove.com/ Surface Electromyographic Biofeedback... Journal of visualized experiments : J...
-
H2S can also protect nerve cells. The objective of the study is to investigate the effects of hydrogen sulfide (H2S) on the expressions of b...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου